Attachment 2 Tailored 52.212-2 Evaluation - Commercial Products and Commercial Services.pdf
PDF 61 KB Posted
- Attached to
- 6505--Radiopharmaceutical Isotopes (Cardiology)
- Solicitation number
- 36C25225Q0333
About this file
This document is an Attachment 2 Tailored 52.212-2 Evaluation for Commercial Products and Commercial Services related to a radiopharmaceutical isotopes solicitation (36C25225Q0333) issued by the Department of Veterans Affairs for the William S. Middleton Memorial Veterans Hospital in Madison, WI. The solicitation covers a five-year contract from 04/01/2025 to 03/31/2030, with a base year and four option years, for providing various radiopharmaceutical isotopes for nuclear cardiology procedures.
The solicitation requires a vendor to provide specific radiopharmaceutical doses including 99mTc-Tetrofosmin, 99mTc-Pertechnatate, 99mTc-methyldiphosphonate, Ultratag RBC Labelling Kit, 67Ga-Gallium Citrate, and 131I-Sodium Iodide. The evaluation will be based on technical features and price, using a comparative evaluation process. Vendors must have current USNRC and/or FDA licenses to produce and distribute radiopharmaceuticals, provide detailed patient dose documentation, and comply with strict delivery and quality control requirements. Quotes are due by 5:00 pm on March 20, 2025, and should be submitted to the Contracting Officer Stacy Massey.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Attachment 1 Tailored FAR 52.212-1 Instructions to Offerors Commercial Products and Commercial Services.pdf | ||
| 36C25225Q0333.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
36C25225Q0333
ATTACHMENT 2:
TAILORED 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL
SERVICES
Effective Date: 03/15/2023
Revision 01
ADDENDUM to 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL
SERVICES
(a) Basis for Award. The Government will issue a purchase order to the responsible quoter whose quotation conforming to the solicitation will be most advantageous to the Government, price and other factors considered.
(b) The following factors shall be used to evaluate quotations:
Technical Features
Price
(c) Evaluation Approach. The Government will evaluate quotations using the comparative evaluation process outlined in FAR 13.106-2 (b) (3), where quotations will be compared to one another to determine which provides the best benefit to the Government. The Government reserves the right to consider a quotation other than the lowest price that provides additional benefit(s). Quotations may exceed minimum requirements of the solicitation. The Government reserves the right to select a quotation that provides benefit to the Government that exceeds the minimum requirements of the solicitation but is not required to do so. Each response must meet the minimum requirements of the solicitation. The Government is requesting or accepting alternate quotations. The evaluation will consider the following:
(1) Technical Features: The quotation will evaluate "equal" products on the basis of information furnished by the offeror or identified in the offer and reasonably. Offeror must clearly indicate in its offer the product being offered is an "equal" product. Equal products must meet the salient physical, functional, and/or performance characteristic specified in solicitation.
(2) Price: The Government will evaluate the price by adding the total of all line-item prices. The
Total Evaluated Price will be that sum.
(d) Options. The Government will evaluate quotations for award purposes by adding the total price for all options to the total price for the basic requirement.
(End of Provision)
File details come from the government source that posted it. Updated .